Gilks CB, Ionescu DN, Kalloger SE, Kobel M, Irving J, Clarke B, Santos J, Le N, Moravan V, Swenerton K: Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Human pathology. 2008, 39: 1239-1251. 10.1016/j.humpath.2008.01.003.
Article
CAS
PubMed
Google Scholar
Silverberg SG: Prognostic significance of pathologic features of ovarian carcinoma. Current topics in pathology. 1989, 78: 85-109.
Article
CAS
PubMed
Google Scholar
Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A: Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer. 2010, 20: 945-952. 10.1111/IGC.0b013e3181dd0110.
Article
PubMed
Google Scholar
Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, et al: Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res. 2009, 15: 2448-2455. 10.1158/1078-0432.CCR-08-2430.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, et al: Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS medicine. 2008, 5: e232-10.1371/journal.pmed.0050232.
Article
PubMed
PubMed Central
Google Scholar
Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, et al: Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. British journal of cancer. 2006, 94: 1369-1374. 10.1038/sj.bjc.6603116.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fader AN, Rose PG: Role of surgery in ovarian carcinoma. J Clin Oncol. 2007, 25: 2873-2883. 10.1200/JCO.2007.11.0932.
Article
PubMed
Google Scholar
Hennessy BT, Coleman RL, Markman M: Ovarian cancer. Lancet. 2009, 374: 1371-1382. 10.1016/S0140-6736(09)61338-6.
Article
CAS
PubMed
Google Scholar
Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, et al: Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer research. 2002, 62: 4722-4729.
CAS
PubMed
Google Scholar
Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ: Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res. 2005, 11: 6422-6430. 10.1158/1078-0432.CCR-05-0508.
Article
CAS
PubMed
Google Scholar
Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, et al: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008, 14: 5198-5208. 10.1158/1078-0432.CCR-08-0196.
Article
CAS
PubMed
Google Scholar
Chen YH, Gao J, Fan G, Peterson LC: Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol. 2010, 23: 105-112. 10.1038/modpathol.2009.140.
Article
CAS
PubMed
Google Scholar
Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadstrom T, Borrebaeck C: Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 2009, 94: 1563-1568. 10.3324/haematol.2009.008474.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA: Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008, 111: 800-805. 10.1182/blood-2007-06-093401.
Article
CAS
PubMed
Google Scholar
Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, Camacho F, Bea S, Hartmann E, Amador V, et al: Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer research. 2010, 70: 1408-1418. 10.1158/0008-5472.CAN-09-3419.
Article
CAS
PubMed
Google Scholar
Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, et al: SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009, 94: 1555-1562. 10.3324/haematol.2009.010264.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, Sander B: The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. British journal of haematology. 2008, 143: 248-252. 10.1111/j.1365-2141.2008.07329.x.
Article
PubMed
Google Scholar
Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, Borrebaeck CA, Ek S: SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Molecular cancer. 2010, 9: 187-10.1186/1476-4598-9-187.
Article
PubMed
PubMed Central
Google Scholar
Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannelly G, O'Connor DP, Gallagher WM, Kilpinen S, Kallioniemi OP, et al: The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 2009, 45: 1510-1517. 10.1016/j.ejca.2009.01.028.
Article
CAS
PubMed
Google Scholar
Berglund G, Elmstahl S, Janzon L, Larsson SA: The Malmo Diet and Cancer Study. Design and feasibility. Journal of internal medicine. 1993, 233: 45-51. 10.1111/j.1365-2796.1993.tb00647.x.
Article
CAS
PubMed
Google Scholar
Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I, Nilsson JA, Stavenow L: Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. Journal of internal medicine. 1996, 239: 489-497. 10.1046/j.1365-2796.1996.483819000.x.
Article
CAS
PubMed
Google Scholar
Ehlen A, Brennan DJ, Nodin B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J, Brandstedt J, Uhlen M, et al: Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. Journal of translational medicine. 2010, 8: 78-10.1186/1479-5876-8-78.
Article
PubMed
PubMed Central
Google Scholar
Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, Landberg G, Duffy MJ, Jirstrom K, Gallagher WM: Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res. 2008, 10: R89-10.1186/bcr2187.
Article
PubMed
PubMed Central
Google Scholar
Manning AP, Mes-Masson AM, Seymour RJ, Tetrault M, Provencher DM, Tonin PN: Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites. Molecular carcinogenesis. 1999, 24: 218-225. 10.1002/(SICI)1098-2744(199903)24:3<218::AID-MC8>3.0.CO;2-A.
Article
CAS
PubMed
Google Scholar
Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF: Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer research. 1983, 43: 5379-5389.
CAS
PubMed
Google Scholar
Lau DH, Ross KL, Sikic BI: Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin. Cancer research. 1990, 50: 4056-4060.
CAS
PubMed
Google Scholar
Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC: Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther. 2004, 10: 1032-1042. 10.1016/j.ymthe.2004.08.013.
Article
CAS
PubMed
Google Scholar
Nodin B, Zendehrokh N, Brandstedt J, Nilsson E, Manjer J, Brennan DJ, Jirstrom K: Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival. J Ovarian Res. 2010, 3: 14-10.1186/1757-2215-3-14.
Article
PubMed
PubMed Central
Google Scholar
Gomez-Raposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A: Molecular characterization of ovarian cancer by gene-expression profiling. Gynecologic oncology. 2010, 118: 88-92. 10.1016/j.ygyno.2010.03.012.
Article
CAS
PubMed
Google Scholar
Bell DA, Scully RE: Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 1994, 73: 1859-1864. 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
Landen CN, Birrer MJ, Sood AK: Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 2008, 26: 995-1005. 10.1200/JCO.2006.07.9970.
Article
PubMed
Google Scholar
Feeley KM, Wells M: Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001, 38: 87-95. 10.1046/j.1365-2559.2001.01042.x.
Article
CAS
PubMed
Google Scholar
Larson BL, Ylostalo J, Lee RH, Gregory C, Prockop DJ: Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue engineering. 2010, 16: 3385-3394. 10.1089/ten.tea.2010.0085.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurman RJ, McConnell TG: Precursors of endometrial and ovarian carcinoma. Virchows Arch. 2010, 456: 1-12. 10.1007/s00428-009-0824-9.
Article
PubMed
Google Scholar
Conrotto P, Andreasson U, Kuci V, Borrebaeck CA, Ek S: Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo. Mol Oncol. 2011
Google Scholar
Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS, Huang TH: Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer research. 2003, 63: 6110-6115.
CAS
PubMed
Google Scholar
Bender CM, Pao MM, Jones PA: Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer research. 1998, 58: 95-101.
CAS
PubMed
Google Scholar
Christman JK: 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002, 21: 5483-5495. 10.1038/sj.onc.1205699.
Article
CAS
PubMed
Google Scholar
Vegliante MC, Royo C, Palomero J, Salaverria I, Balint B, Martin-Guerrero I, Agirre X, Lujambio A, Richter J, Xargay-Torrent S, et al: Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. PLoS One. 2011, 6: e21382-10.1371/journal.pone.0021382.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matei DE, Nephew KP: Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. Gynecologic oncology. 2010, 116: 195-201. 10.1016/j.ygyno.2009.09.043.
Article
CAS
PubMed
Google Scholar
Gadducci A, Cosio S, Tana R, Genazzani AR: Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Critical reviews in oncology/hematology. 2009, 69: 12-27. 10.1016/j.critrevonc.2008.05.001.
Article
PubMed
Google Scholar